25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AVDL (Avadel) Stock Analysis
Buy, Hold or Sell?

Let's analyze Avadel together

I guess you are interested in Avadel Pharmaceuticals PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Avadel’s Financial Insights
  • 📈 Technical Analysis (TA) – Avadel’s Price Targets

I'm going to help you getting a better view of Avadel Pharmaceuticals PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Avadel Pharmaceuticals PLC

I send you an email if I find something interesting about Avadel Pharmaceuticals PLC.

1. Quick Overview

1.1. Quick analysis of Avadel (30 sec.)










1.2. What can you expect buying and holding a share of Avadel? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$0.77
Expected worth in 1 year
$0.72
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.04
Return On Investment
-0.5%

For what price can you sell your share?

Current Price per Share
$8.93
Expected price per share
$6.38 - $10.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Avadel (5 min.)




Live pricePrice per Share (EOD)
$8.93
Intrinsic Value Per Share
$-10.54 - $10.65
Total Value Per Share
$-9.78 - $11.42

2.2. Growth of Avadel (5 min.)




Is Avadel growing?

Current yearPrevious yearGrowGrow %
How rich?$74m$104.8m-$31.6m-43.2%

How much money is Avadel making?

Current yearPrevious yearGrowGrow %
Making money-$6.6m-$39.2m$32.6m493.8%
Net Profit Margin-14.5%-1,268.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Avadel (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Avadel?

Welcome investor! Avadel's management wants to use your money to grow the business. In return you get a share of Avadel.

First you should know what it really means to hold a share of Avadel. And how you can make/lose money.

Speculation

The Price per Share of Avadel is $8.93. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avadel.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avadel, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.77. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avadel.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-0.6%-0.07-0.8%-0.41-4.5%-0.31-3.5%-0.23-2.6%-0.14-1.5%
Usd Book Value Change Per Share0.000.0%-0.01-0.1%0.303.4%0.020.2%0.020.2%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Total Gains Per Share0.000.0%-0.01-0.1%0.303.4%0.020.2%0.020.2%0.020.2%
Usd Price Per Share7.83-11.38-14.45-10.59-9.37-9.14-
Price to Earnings Ratio-38.49--58.58--9.96--24.24--17.98--19.95-
Price-to-Total Gains Ratio3,412.01-571.62--64.24-153.39-77.20-47.02-
Price to Book Ratio10.23-15.08-14.15--4.07-0.28-12.41-
Price-to-Total Gains Ratio3,412.01-571.62--64.24-153.39-77.20-47.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.93
Number of shares111
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.02
Usd Total Gains Per Share-0.010.02
Gains per Quarter (111 shares)-1.242.41
Gains per Year (111 shares)-4.959.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5-150100
20-10-2001910
30-15-2502920
40-20-3003930
50-25-3504840
60-30-4005850
70-35-4506760
80-40-5007770
90-45-5508780
100-49-6009690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%6.034.00.015.0%23.078.00.022.8%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%12.027.01.030.0%32.063.06.031.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%1.00.0100.01.0%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%12.027.01.030.0%32.063.06.031.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Avadel Pharmaceuticals PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.002-0.011+586%0.301-99%0.016-86%0.022-89%0.013-83%
Book Value Per Share--0.7660.757+1%1.084-29%0.549+39%0.848-10%0.629+22%
Current Ratio--2.7342.819-3%3.250-16%2.7420%6.905-60%4.785-43%
Debt To Asset Ratio--0.5590.548+2%0.486+15%0.723-23%0.663-16%0.760-26%
Debt To Equity Ratio--1.2671.213+4%1.091+16%0.768+65%1.064+19%3.934-68%
Dividend Per Share----0%-0%-0%-0%0.005-100%
Enterprise Value--730070555.6801081357712.860-32%1421123199.960-49%1005426850.767-27%908620493.004-20%850509292.046-14%
Eps---0.051-0.068+34%-0.405+697%-0.309+508%-0.235+362%-0.136+167%
Ev To Ebitda Ratio---60.819-2.639-96%-10.980-82%-6.401-89%-10.328-83%-7.681-87%
Ev To Sales Ratio--3.4765.696-39%88.237-96%46.967-93%40.695-91%17.755-80%
Free Cash Flow Per Share---0.085-0.066-23%-0.331+289%-0.191+124%-0.191+125%-0.125+47%
Free Cash Flow To Equity Per Share---0.078-0.057-27%-0.036-54%-0.049-37%-0.044-43%-0.021-73%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.064-6%1.103-9%
Intrinsic Value_10Y_max--10.653----------
Intrinsic Value_10Y_min---10.544----------
Intrinsic Value_1Y_max---0.274----------
Intrinsic Value_1Y_min---0.818----------
Intrinsic Value_3Y_max--0.199----------
Intrinsic Value_3Y_min---2.679----------
Intrinsic Value_5Y_max--1.904----------
Intrinsic Value_5Y_min---4.768----------
Market Cap863878341.280+12%757465555.6801100767712.860-31%1397635199.960-46%1024424600.767-26%906225793.004-16%883746092.046-14%
Net Profit Margin---0.094-0.145+55%-12.682+13435%-4.276+4463%-2.453+2519%-1.368+1360%
Operating Margin----0.0800%-12.1560%-4.0780%-2.5170%-1.3510%
Operating Ratio--1.0571.109-5%11.090-90%4.066-74%2.571-59%1.783-41%
Pb Ratio11.663+12%10.22615.085-32%14.148-28%-4.070+140%0.285+3492%12.413-18%
Pe Ratio-43.896-14%-38.489-58.581+52%-9.964-74%-24.239-37%-17.982-53%-19.949-48%
Price Per Share8.930+12%7.83011.379-31%14.448-46%10.590-26%9.368-16%9.135-14%
Price To Free Cash Flow Ratio-26.235-14%-23.004-13.863-40%-11.224-51%-11.562-50%-11.713-49%-7.884-66%
Price To Total Gains Ratio3891.344+12%3412.007571.621+497%-64.244+102%153.386+2124%77.198+4320%47.019+7157%
Quick Ratio--2.3202.896-20%4.703-51%3.460-33%10.001-77%7.084-67%
Return On Assets---0.029-0.041+40%-0.193+559%-0.158+441%-0.115+291%-0.069+135%
Return On Equity---0.066-0.092+38%-0.364+448%-0.152+129%-0.152+129%-0.721+985%
Total Gains Per Share--0.002-0.011+586%0.301-99%0.016-86%0.022-89%0.018-87%
Usd Book Value--74070000.00073217250.000+1%104866000.000-29%53104166.667+39%82032900.000-10%60876175.000+22%
Usd Book Value Change Per Share--0.002-0.011+586%0.301-99%0.016-86%0.022-89%0.013-83%
Usd Book Value Per Share--0.7660.757+1%1.084-29%0.549+39%0.848-10%0.629+22%
Usd Dividend Per Share----0%-0%-0%-0%0.005-100%
Usd Enterprise Value--730070555.6801081357712.860-32%1421123199.960-49%1005426850.767-27%908620493.004-20%850509292.046-14%
Usd Eps---0.051-0.068+34%-0.405+697%-0.309+508%-0.235+362%-0.136+167%
Usd Free Cash Flow---8232000.000-6358750.000-23%-31995500.000+289%-18445083.333+124%-18495857.144+125%-12112928.572+47%
Usd Free Cash Flow Per Share---0.085-0.066-23%-0.331+289%-0.191+124%-0.191+125%-0.125+47%
Usd Free Cash Flow To Equity Per Share---0.078-0.057-27%-0.036-54%-0.049-37%-0.044-43%-0.021-73%
Usd Market Cap863878341.280+12%757465555.6801100767712.860-31%1397635199.960-46%1024424600.767-26%906225793.004-16%883746092.046-14%
Usd Price Per Share8.930+12%7.83011.379-31%14.448-46%10.590-26%9.368-16%9.135-14%
Usd Profit---4920000.000-6602500.000+34%-39208500.000+697%-27089000.000+451%-21046400.000+328%-12448850.000+153%
Usd Revenue--52511000.00048612500.000+8%13785250.000+281%20799250.000+152%13695550.000+283%22802700.000+130%
Usd Total Gains Per Share--0.002-0.011+586%0.301-99%0.016-86%0.022-89%0.018-87%
 EOD+6 -2MRQTTM+19 -17YOY+16 -203Y+19 -175Y+16 -2110Y+21 -18

3.3 Fundamental Score

Let's check the fundamental score of Avadel Pharmaceuticals PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-43.896
Price to Book Ratio (EOD)Between0-111.663
Net Profit Margin (MRQ)Greater than0-0.094
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.320
Current Ratio (MRQ)Greater than12.734
Debt to Asset Ratio (MRQ)Less than10.559
Debt to Equity Ratio (MRQ)Less than11.267
Return on Equity (MRQ)Greater than0.15-0.066
Return on Assets (MRQ)Greater than0.05-0.029
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Avadel Pharmaceuticals PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.740
Ma 20Greater thanMa 509.405
Ma 50Greater thanMa 1009.177
Ma 100Greater thanMa 2008.611
OpenGreater thanClose8.890
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland.

Fundamental data was last updated by Penke on 2025-06-19 00:15:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Avadel earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -9.4% means that $-0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -9.4%. The company is making a loss. -1
  • The TTM is -14.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-14.5%+5.1%
TTM-14.5%YOY-1,268.2%+1,253.7%
TTM-14.5%5Y-245.3%+230.9%
5Y-245.3%10Y-136.8%-108.5%
4.3.1.2. Return on Assets

Shows how efficient Avadel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.9% Return on Assets means that Avadel generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-4.1%+1.2%
TTM-4.1%YOY-19.3%+15.2%
TTM-4.1%5Y-11.5%+7.3%
5Y-11.5%10Y-6.9%-4.6%
4.3.1.3. Return on Equity

Shows how efficient Avadel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.6% Return on Equity means Avadel generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avadel Pharmaceuticals PLC:

  • The MRQ is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-9.2%+2.5%
TTM-9.2%YOY-36.4%+27.2%
TTM-9.2%5Y-15.2%+6.0%
5Y-15.2%10Y-72.1%+56.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Avadel Pharmaceuticals PLC.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Avadel is operating .

  • Measures how much profit Avadel makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-8.0%+8.0%
TTM-8.0%YOY-1,215.6%+1,207.6%
TTM-8.0%5Y-251.7%+243.7%
5Y-251.7%10Y-135.1%-116.6%
4.3.2.2. Operating Ratio

Measures how efficient Avadel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.06 means that the operating costs are $1.06 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 1.057. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.109. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.057TTM1.109-0.052
TTM1.109YOY11.090-9.981
TTM1.1095Y2.571-1.462
5Y2.57110Y1.783+0.788
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Avadel Pharmaceuticals PLC.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Avadel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.73 means the company has $2.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 2.734. The company is able to pay all its short-term debts. +1
  • The TTM is 2.819. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.734TTM2.819-0.085
TTM2.819YOY3.250-0.430
TTM2.8195Y6.905-4.086
5Y6.90510Y4.785+2.121
4.4.3.2. Quick Ratio

Measures if Avadel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.32 means the company can pay off $2.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 2.320. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.896. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.320TTM2.896-0.576
TTM2.896YOY4.703-1.806
TTM2.8965Y10.001-7.104
5Y10.00110Y7.084+2.917
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Avadel Pharmaceuticals PLC.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Avadel assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avadel to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.56 means that Avadel assets are financed with 55.9% credit (debt) and the remaining percentage (100% - 55.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 0.559. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.548. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.559TTM0.548+0.011
TTM0.548YOY0.486+0.062
TTM0.5485Y0.663-0.115
5Y0.66310Y0.760-0.097
4.5.4.2. Debt to Equity Ratio

Measures if Avadel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 126.7% means that company has $1.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avadel Pharmaceuticals PLC:

  • The MRQ is 1.267. The company is able to pay all its debts with equity. +1
  • The TTM is 1.213. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.267TTM1.213+0.054
TTM1.213YOY1.091+0.122
TTM1.2135Y1.064+0.149
5Y1.06410Y3.934-2.869
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avadel generates.

  • Above 15 is considered overpriced but always compare Avadel to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -38.49 means the investor is paying $-38.49 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is -43.896. Based on the earnings, the company is expensive. -2
  • The MRQ is -38.489. Based on the earnings, the company is expensive. -2
  • The TTM is -58.581. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-43.896MRQ-38.489-5.407
MRQ-38.489TTM-58.581+20.092
TTM-58.581YOY-9.964-48.617
TTM-58.5815Y-17.982-40.599
5Y-17.98210Y-19.949+1.967
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is -26.235. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.863. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.235MRQ-23.004-3.232
MRQ-23.004TTM-13.863-9.141
TTM-13.863YOY-11.224-2.638
TTM-13.8635Y-11.713-2.150
5Y-11.71310Y-7.884-3.829
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Avadel is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Avadel Pharmaceuticals PLC:

  • The EOD is 11.663. Based on the equity, the company is expensive. -2
  • The MRQ is 10.226. Based on the equity, the company is expensive. -2
  • The TTM is 15.085. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.663MRQ10.226+1.437
MRQ10.226TTM15.085-4.858
TTM15.085YOY14.148+0.936
TTM15.0855Y0.285+14.800
5Y0.28510Y12.413-12.128
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avadel Pharmaceuticals PLC.

4.8.1. Institutions holding Avadel Pharmaceuticals PLC

Institutions are holding 83.294% of the shares of Avadel Pharmaceuticals PLC.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31HHG PLC14.05050.059713592334-487885-3.465
2025-03-31Gendell Jeffrey L6.33372.07136127156-203279-3.2111
2025-03-31Brandes Investment Partners & Co5.85820.451356671753494036160.7829
2025-03-31BlackRock Inc5.63740.00095453526141180.2596
2025-03-31Two Seas Capital LP5.11321.2202494644965000015.1288
2025-03-31Polar Capital Holdings PLC4.50280.20774355964-58236-1.3193
2025-03-31Vanguard Group Inc4.03630.00063904650-48597-1.2293
2025-03-31Vivo Capital, LLC2.77462.7834268410900
2025-03-31WEALTH EFFECTS LLC2.4497.79212369122249921.0662
2025-03-31Citadel Advisors Llc2.32070.00332245010-348528-13.4383
2025-03-31TANG CAPITAL MANAGEMENT LLC2.16820.9086209750060000040.0668
2025-03-31State Street Corp1.71520.00051659306-26833-1.5914
2024-12-31UBS Group AG1.62380.00311570860963556158.6612
2025-03-31Geode Capital Management, LLC1.22970.00071189596243452.0892
2025-03-31Bank of America Corp1.15580.0007111809010350511246.4637
2025-03-31Morgan Stanley - Brokerage Accounts1.06950.00061034614-174782-14.452
2025-03-31Samsara BioCapital, LLC1.00011.350996752700
2025-03-31Krensavage Asset Management, LLC0.9824.11269500009500000
2025-03-31Woodline Partners LP0.92710.045789686139504078.7213
2025-03-31Kennedy Capital Management Inc0.77950.141754043-302891-28.6575
Total 65.727321.154963583892+6500107+10.2%

4.9.2. Funds holding Avadel Pharmaceuticals PLC

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Polar Capital Healthcare Opports Inc3.73842.031361644600
2025-04-30Vanguard Total Stock Mkt Idx Inv3.00380.00152905817695002.4504
2025-03-31Janus Henderson Global Life Sciences2.56530.41312481651-59938-2.3583
2025-03-31Janus Henderson Global Life Sciences D2.56530.41352481651-9175-0.3684
2025-05-31iShares Russell 2000 ETF2.39850.0343232025000
2025-03-31Janus Global Life Science AUSD2.08580.41332017817-16049-0.7891
2025-04-30Janus Henderson Glb Life Scn I2 USD2.05580.47231988806-29011-1.4377
2025-03-31Janus Henderson US Small Cap Growth1.53040.400814804467280.0492
2025-03-31Janus Henderson Venture D1.53040.400214804467280.0492
2025-04-30Brandes European Value I USD1.09151.1106105594327450235.1277
2025-03-31Janus Henderson Hrzn Biotec E2 USD1.08681.6633105140011159411.8742
2025-03-31Fidelity Small Cap Index0.9590.030192770344120.4779
2025-03-31Brandes International Small Cap Equity A0.88340.843885455428257049.4017
2025-05-31iShares Russell 2000 Growth ETF0.82860.066180156200
2025-03-31Brandes International Small Cap Eq0.61720.7716597113327913121.8102
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.6140.013259402200
2025-05-31SEB Läkemedelsfond0.56910.368355051800
2025-05-31Brandes Global Small Cap Equity Cl F0.51650.78214997045260611.7661
2025-04-30Vanguard Russell 2000 ETF0.47890.0349463260289496.6655
2025-04-30DWS Small Cap Core S0.43930.465142500000
Total 29.55810.729128594109+1039329+3.6%

5.3. Insider Transactions

Insiders are holding 4.917% of the shares of Avadel Pharmaceuticals PLC.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-01-21Linda PalczukBUY50007.93
2025-01-13Peter J ThorntonBUY100008.04
2024-12-13Thomas S MchughBUY230010.44
2024-12-11Thomas S MchughBUY500010.49
2024-12-10Geoffrey Michael GlassBUY202799.84
2024-12-09Gregory J DivisBUY4029.82
2024-12-06Gregory J DivisBUY95989.98
2024-12-06Linda PalczukBUY300010.19
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets167,949
Total Liabilities93,879
Total Stockholder Equity74,070
 As reported
Total Liabilities 93,879
Total Stockholder Equity+ 74,070
Total Assets = 167,949

Assets

Total Assets167,949
Total Current Assets139,258
Long-term Assets28,691
Total Current Assets
Cash And Cash Equivalents 56,370
Short-term Investments 10,114
Net Receivables 41,581
Inventory 20,406
Other Current Assets 10,787
Total Current Assets  (as reported)139,258
Total Current Assets  (calculated)139,258
+/-0
Long-term Assets
Property Plant Equipment 3,203
Goodwill 16,836
Long-term Assets Other 8,652
Long-term Assets  (as reported)28,691
Long-term Assets  (calculated)28,691
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities50,933
Long-term Liabilities42,946
Total Stockholder Equity74,070
Total Current Liabilities
Short-term Debt 706
Accounts payable 9,116
Other Current Liabilities 31,995
Total Current Liabilities  (as reported)50,933
Total Current Liabilities  (calculated)41,817
+/- 9,116
Long-term Liabilities
Capital Lease Obligations 2,895
Long-term Liabilities Other 35,518
Long-term Liabilities  (as reported)42,946
Long-term Liabilities  (calculated)38,413
+/- 4,533
Total Stockholder Equity
Common Stock966
Retained Earnings -799,247
Accumulated Other Comprehensive Income -24,312
Other Stockholders Equity 896,663
Total Stockholder Equity (as reported)74,070
Total Stockholder Equity (calculated)74,070
+/-0
Other
Capital Stock966
Cash and Short Term Investments 66,484
Common Stock Shares Outstanding 96,601
Liabilities and Stockholders Equity 167,949
Net Debt -53,475
Net Invested Capital 74,070
Net Working Capital 88,325
Property Plant and Equipment Gross 11,665
Short Long Term Debt Total 2,895



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-31
> Total Assets 
4,700
4,700
4,700
29,900
29,900
29,900
29,900
21,500
18,900
18,900
18,900
25,318
25,318
25,318
25,318
14,920
12,865
23,131
20,531
20,360
17,376
17,376
15,598
18,144
18,144
18,144
21,674
23,076
23,580
23,856
33,022
127,252
127,590
124,230
124,230
145,608
145,950
142,585
127,972
124,351
116,278
113,648
111,262
114,894
108,461
106,435
103,911
105,197
105,197
101,091
88,767
91,080
91,080
93,253
97,921
94,296
81,255
70,480
77,384
74,614
69,980
76,114
72,697
69,402
137,411
133,715
117,311
117,311
122,733
118,408
116,514
116,252
181,743
174,631
164,385
174,207
186,410
186,546
186,546
214,977
255,010
249,013
247,985
245,482
258,688
259,160
277,427
252,106
351,861
295,236
269,006
190,300
173,622
165,709
155,888
151,436
207,725
341,401
327,635
311,637
292,941
282,591
264,089
247,265
221,127
157,938
145,758
132,785
140,739
200,976
203,100
261,126
167,899
157,521
158,253
164,236
167,949
167,949164,236158,253157,521167,899261,126203,100200,976140,739132,785145,758157,938221,127247,265264,089282,591292,941311,637327,635341,401207,725151,436155,888165,709173,622190,300269,006295,236351,861252,106277,427259,160258,688245,482247,985249,013255,010214,977186,546186,546186,410174,207164,385174,631181,743116,252116,514118,408122,733117,311117,311133,715137,41169,40272,69776,11469,98074,61477,38470,48081,25594,29697,92193,25391,08091,08088,767101,091105,197105,197103,911106,435108,461114,894111,262113,648116,278124,351127,972142,585145,950145,608124,230124,230127,590127,25233,02223,85623,58023,07621,67418,14418,14418,14415,59817,37617,37620,36020,53123,13112,86514,92025,31825,31825,31825,31818,90018,90018,90021,50029,90029,90029,90029,9004,7004,7004,700
   > Total Current Assets 
2,500
0
0
17,800
0
0
0
14,600
11,800
0
0
16,436
0
0
0
7,752
0
0
0
14,061
0
0
0
13,799
13,799
0
18,256
18,711
19,218
19,662
28,588
120,735
117,848
111,066
111,066
120,772
123,421
116,786
101,604
91,988
83,708
80,037
78,750
76,779
68,148
62,668
61,605
56,977
56,977
52,265
49,601
59,192
59,192
59,002
69,239
66,841
56,780
47,223
50,246
45,362
36,913
41,989
40,023
36,652
32,604
30,282
25,085
25,085
39,244
34,949
32,931
33,623
108,725
105,121
99,248
112,322
129,334
132,167
0
166,306
180,474
177,648
177,854
181,186
204,612
204,351
148,933
123,954
231,933
174,976
147,876
124,851
102,437
97,200
88,602
82,380
130,975
277,019
281,688
263,454
242,314
230,702
205,820
192,490
160,741
125,713
113,222
100,843
109,470
171,230
172,255
134,202
136,035
125,780
127,258
134,208
139,258
139,258134,208127,258125,780136,035134,202172,255171,230109,470100,843113,222125,713160,741192,490205,820230,702242,314263,454281,688277,019130,97582,38088,60297,200102,437124,851147,876174,976231,933123,954148,933204,351204,612181,186177,854177,648180,474166,3060132,167129,334112,32299,248105,121108,72533,62332,93134,94939,24425,08525,08530,28232,60436,65240,02341,98936,91345,36250,24647,22356,78066,84169,23959,00259,19259,19249,60152,26556,97756,97761,60562,66868,14876,77978,75080,03783,70891,988101,604116,786123,421120,772111,066111,066117,848120,73528,58819,66219,21818,71118,256013,79913,79900014,0610007,75200016,4360011,80014,60000017,800002,500
       Cash And Cash Equivalents 
1,200
0
0
15,500
0
0
0
3,800
6,000
0
0
7,277
0
0
0
5,210
0
0
0
10,137
0
0
0
5,309
5,309
0
14,623
14,527
14,319
11,649
22,076
109,617
105,435
100,850
100,850
4,591
1,332
914
1,606
1,018
2,598
5,544
564
51,827
44,444
36,820
29,538
31,608
31,608
22,701
28,405
17,853
17,853
7,205
4,784
8,716
995
3,570
3,909
8,184
5,831
11,584
6,729
3,456
4,348
4,755
2,742
2,742
14,010
8,336
7,807
6,636
55,505
54,104
24,006
39,760
38,535
55,236
0
65,064
37,870
23,899
18,780
39,215
32,236
43,507
37,449
16,564
40,911
12,477
17,837
9,325
9,630
17,111
12,867
9,774
73,506
102,174
83,109
71,722
59,172
67,142
58,169
50,708
60,873
54,128
60,715
73,981
83,391
49,985
51,811
31,167
35,794
28,847
28,582
51,371
56,370
56,37051,37128,58228,84735,79431,16751,81149,98583,39173,98160,71554,12860,87350,70858,16967,14259,17271,72283,109102,17473,5069,77412,86717,1119,6309,32517,83712,47740,91116,56437,44943,50732,23639,21518,78023,89937,87065,064055,23638,53539,76024,00654,10455,5056,6367,8078,33614,0102,7422,7424,7554,3483,4566,72911,5845,8318,1843,9093,5709958,7164,7847,20517,85317,85328,40522,70131,60831,60829,53836,82044,44451,8275645,5442,5981,0181,6069141,3324,591100,850100,850105,435109,61722,07611,64914,31914,52714,62305,3095,30900010,1370005,2100007,277006,0003,80000015,500001,200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,418
0
0
0
100,783
107,497
101,680
87,812
82,756
72,608
63,598
66,015
10,944
8,274
10,145
11,218
7,670
7,670
11,787
4,414
21,209
21,209
37,862
44,026
35,352
34,377
30,155
28,132
23,160
20,172
21,395
22,728
21,035
18,376
15,686
6,413
6,413
1,358
1,387
1,473
401
28,018
23,753
52,496
53,074
74,637
60,884
0
79,738
122,084
130,964
130,887
114,980
146,978
130,290
78,161
77,511
157,269
134,629
107,425
90,590
70,221
62,151
59,587
54,384
39,977
136,380
148,467
149,680
145,803
135,701
122,924
106,513
62,608
49,993
45,760
22,518
17,532
110,525
101,368
73,944
52,995
42,535
37,225
22,406
10,114
10,11422,40637,22542,53552,99573,944101,368110,52517,53222,51845,76049,99362,608106,513122,924135,701145,803149,680148,467136,38039,97754,38459,58762,15170,22190,590107,425134,629157,26977,51178,161130,290146,978114,980130,887130,964122,08479,738060,88474,63753,07452,49623,75328,0184011,4731,3871,3586,4136,41315,68618,37621,03522,72821,39520,17223,16028,13230,15534,37735,35244,02637,86221,20921,2094,41411,7877,6707,67011,21810,1458,27410,94466,01563,59872,60882,75687,812101,680107,497100,783000108,4180000000000000000000000000000000
       Net Receivables 
500
0
0
1,000
0
0
0
3,300
1,300
0
0
3,195
0
0
0
1,611
0
0
0
2,641
0
0
0
7,596
7,596
0
2,938
3,462
3,503
6,008
4,347
8,367
7,754
5,212
5,212
8,203
8,458
7,255
6,238
2,583
3,207
5,928
7,767
8,988
6,497
7,553
13,052
12,306
12,306
12,015
12,465
15,755
15,755
8,686
15,234
18,075
15,958
8,302
12,580
9,784
7,485
5,875
6,282
7,844
5,580
5,570
13,109
13,109
20,231
21,583
17,826
6,204
4,040
3,637
2,988
1,679
8,688
5,107
0
14,494
6,415
9,488
15,395
17,839
15,310
19,285
24,080
16,509
18,229
16,696
11,447
13,912
14,138
12,110
8,725
8,281
11,425
33,607
46,754
3,326
30,451
21,692
21,282
2,443
31,509
17,231
2,158
2,248
2,283
1,775
6,239
13,425
23,985
34,304
37,102
34,097
41,581
41,58134,09737,10234,30423,98513,4256,2391,7752,2832,2482,15817,23131,5092,44321,28221,69230,4513,32646,75433,60711,4258,2818,72512,11014,13813,91211,44716,69618,22916,50924,08019,28515,31017,83915,3959,4886,41514,49405,1078,6881,6792,9883,6374,0406,20417,82621,58320,23113,10913,1095,5705,5807,8446,2825,8757,4859,78412,5808,30215,95818,07515,2348,68615,75515,75512,46512,01512,30612,30613,0527,5536,4978,9887,7675,9283,2072,5836,2387,2558,4588,2035,2125,2127,7548,3674,3476,0083,5033,4622,93807,5967,5960002,6410001,6110003,195001,3003,3000001,00000500
       Inventory 
200
0
0
200
0
0
0
100
200
0
0
804
0
0
0
186
447
454
666
860
695
0
810
569
569
0
351
375
531
1,069
545
1,057
991
1,310
1,310
1,597
1,129
966
1,171
1,050
974
1,265
1,354
3,332
3,077
3,064
2,948
2,218
2,218
2,194
1,683
2,093
2,093
2,592
2,157
1,072
826
932
1,070
862
854
906
1,699
1,675
1,903
1,599
1,520
1,520
1,884
1,854
2,892
3,762
5,132
5,564
6,473
6,729
5,497
5,751
0
4,155
5,312
3,640
3,909
3,258
5,406
5,747
5,870
6,157
5,948
5,724
6,030
4,770
4,258
2,601
2,260
3,570
3,523
4,154
2,903
0
6,467
5,401
2,787
0
5,317
3,881
3,745
0
0
1,439
5,286
10,380
11,928
13,313
16,097
20,298
20,406
20,40620,29816,09713,31311,92810,3805,2861,439003,7453,8815,31702,7875,4016,46702,9034,1543,5233,5702,2602,6014,2584,7706,0305,7245,9486,1575,8705,7475,4063,2583,9093,6405,3124,15505,7515,4976,7296,4735,5645,1323,7622,8921,8541,8841,5201,5201,5991,9031,6751,6999068548621,0709328261,0722,1572,5922,0932,0931,6832,1942,2182,2182,9483,0643,0773,3321,3541,2659741,0501,1719661,1291,5971,3101,3109911,0575451,069531375351056956981006958606664544471860008040020010000020000200
       Other Current Assets 
600
0
0
1,100
0
0
0
7,400
4,300
0
0
5,160
0
0
0
745
741
738
318
423
532
0
469
325
325
0
344
347
865
936
1,620
1,694
3,668
3,694
3,694
5,598
5,005
5,971
4,777
4,581
4,321
3,702
3,050
1,688
5,856
5,086
4,849
3,175
3,175
3,568
2,634
2,282
2,282
2,657
3,038
3,626
4,624
4,264
4,555
3,372
2,571
2,229
2,585
1,614
2,397
2,672
1,301
1,301
1,761
1,789
2,933
17,972
16,030
18,063
13,285
11,080
10,665
5,189
0
3,344
8,793
9,657
13,339
5,894
4,682
5,522
3,373
7,234
9,576
5,450
5,137
6,254
4,190
3,227
5,163
6,371
2,544
4,858
3,358
3,270
6,888
6,167
3,445
35,269
5,751
4,361
4,589
4,344
8,547
7,506
7,551
5,286
11,333
6,781
8,252
6,036
10,787
10,7876,0368,2526,78111,3335,2867,5517,5068,5474,3444,5894,3615,75135,2693,4456,1676,8883,2703,3584,8582,5446,3715,1633,2274,1906,2545,1375,4509,5767,2343,3735,5224,6825,89413,3399,6578,7933,34405,18910,66511,08013,28518,06316,03017,9722,9331,7891,7611,3011,3012,6722,3971,6142,5852,2292,5713,3724,5554,2644,6243,6263,0382,6572,2822,2822,6343,5683,1753,1754,8495,0865,8561,6883,0503,7024,3214,5814,7775,9715,0055,5983,6943,6943,6681,6941,620936865347344032532546905324233187387417450005,160004,3007,4000001,10000600
   > Long-term Assets 
2,200
0
0
12,100
0
0
0
6,900
7,100
0
0
8,882
0
0
0
7,168
0
0
0
6,299
0
0
0
4,345
4,345
0
3,418
4,365
4,362
4,194
4,434
6,517
9,742
13,164
13,164
24,836
22,529
25,799
26,368
32,363
32,570
33,611
32,512
38,115
40,313
43,767
42,306
48,220
48,220
48,826
39,166
31,888
31,888
34,251
28,682
27,455
24,475
23,257
27,138
29,252
33,067
34,125
32,674
32,750
104,807
103,433
92,226
92,226
83,489
83,459
83,583
82,629
73,018
69,510
65,137
61,885
57,076
54,379
0
48,671
74,536
71,365
70,131
64,296
54,076
54,809
128,494
128,152
119,928
120,260
121,130
65,449
71,185
68,509
67,286
69,056
76,750
64,382
45,947
48,183
50,627
51,889
58,269
54,775
60,386
32,225
32,536
31,942
31,269
29,746
30,845
126,924
31,864
31,741
30,995
30,028
28,691
28,69130,02830,99531,74131,864126,92430,84529,74631,26931,94232,53632,22560,38654,77558,26951,88950,62748,18345,94764,38276,75069,05667,28668,50971,18565,449121,130120,260119,928128,152128,49454,80954,07664,29670,13171,36574,53648,671054,37957,07661,88565,13769,51073,01882,62983,58383,45983,48992,22692,226103,433104,80732,75032,67434,12533,06729,25227,13823,25724,47527,45528,68234,25131,88831,88839,16648,82648,22048,22042,30643,76740,31338,11532,51233,61132,57032,36326,36825,79922,52924,83613,16413,1649,7426,5174,4344,1944,3624,3653,41804,3454,3450006,2990007,1680008,882007,1006,90000012,100002,200
       Property Plant Equipment 
1,100
0
0
1,700
0
0
0
4,100
4,300
0
0
4,618
0
0
0
3,502
3,292
3,177
2,742
2,922
2,722
0
2,706
2,672
2,672
0
3,095
3,405
3,342
3,431
3,658
5,085
8,331
11,747
11,747
18,162
16,108
19,863
20,460
22,317
22,262
23,433
22,376
25,705
27,739
31,013
34,201
36,115
36,115
34,473
29,890
25,065
25,065
25,734
25,936
24,759
22,547
20,438
22,677
21,425
22,744
22,462
20,409
19,383
19,645
18,041
18,238
18,238
17,271
17,271
17,352
17,435
17,170
16,605
15,182
1,777
1,777
1,978
0
2,616
3,100
3,104
3,186
3,320
3,382
3,328
3,180
3,001
2,722
7,315
8,248
7,805
13,378
12,949
5,155
4,156
10,199
8,725
8,440
2,963
8,321
8,319
9,445
2,937
12,760
13,032
13,822
2,552
2,257
1,950
3,452
3,176
2,900
2,638
2,399
2,155
3,203
3,2032,1552,3992,6382,9003,1763,4521,9502,2572,55213,82213,03212,7602,9379,4458,3198,3212,9638,4408,72510,1994,1565,15512,94913,3787,8058,2487,3152,7223,0013,1803,3283,3823,3203,1863,1043,1002,61601,9781,7771,77715,18216,60517,17017,43517,35217,27117,27118,23818,23818,04119,64519,38320,40922,46222,74421,42522,67720,43822,54724,75925,93625,73425,06525,06529,89034,47336,11536,11534,20131,01327,73925,70522,37623,43322,26222,31720,46019,86316,10818,16211,74711,7478,3315,0853,6583,4313,3423,4053,09502,6722,6722,70602,7222,9222,7423,1773,2923,5020004,618004,3004,1000001,700001,100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,461
20,461
18,491
18,491
18,491
18,491
18,490
18,491
18,491
18,491
18,490
18,491
18,491
18,491
0
18,491
24,055
18,669
19,134
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
18,491
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,836
16,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83616,83618,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49118,49119,13418,66924,05518,491018,49118,49118,49118,49018,49118,49118,49118,49018,49118,49118,49118,49120,46120,4610000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
300
0
0
200
0
0
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49,250
49,089
41,589
41,589
41,424
41,259
41,094
40,139
37,202
34,264
31,326
28,390
25,249
22,108
0
15,825
32,911
29,209
25,508
22,837
22,274
21,709
94,256
92,289
72,571
70,962
69,339
1,629
1,428
1,224
1,019
813
610
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000006108131,0191,2241,4281,62969,33970,96272,57192,28994,25621,70922,27422,83725,50829,20932,91115,825022,10825,24928,39031,32634,26437,20240,13941,09441,25941,42441,58941,58949,08949,2500000000000000000000000000000000000000000000000000000000010000020000300
       Long-term Assets Other 
800
0
0
10,200
0
0
0
2,700
2,800
0
0
4,264
0
0
0
3,666
0
0
0
3,377
0
0
0
1,673
1,673
0
323
960
1,020
763
776
1,432
1,411
1,417
1,417
6,674
6,421
5,936
5,908
10,046
10,308
10,178
10,136
12,410
12,574
12,754
8,105
12,105
12,105
14,353
9,276
6,823
6,823
8,517
2,746
2,696
1,928
2,819
4,461
7,827
10,323
11,663
12,265
13,203
15,276
15,669
13,908
13,908
6,303
6,438
6,647
6,564
155
150
139
125
115
117
0
158
16
4,968
6,820
7,531
101
8,242
1,910
9,099
10,163
6,077
5,944
5,746
5,604
5,463
34,927
39,274
1,825
1,757
1,584
24,939
1,377
1,267
-120,734
-95,639
2,212
2,357
1,878
-60,019
12,176
10,960
10,557
10,152
11,768
12,015
11,760
11,037
8,652
8,65211,03711,76012,01511,76810,15210,55710,96012,176-60,0191,8782,3572,212-95,639-120,7341,2671,37724,9391,5841,7571,82539,27434,9275,4635,6045,7465,9446,07710,1639,0991,9108,2421017,5316,8204,9681615801171151251391501556,5646,6476,4386,30313,90813,90815,66915,27613,20312,26511,66310,3237,8274,4612,8191,9282,6962,7468,5176,8236,8239,27614,35312,10512,1058,10512,75412,57412,41010,13610,17810,30810,0465,9085,9366,4216,6741,4171,4171,4111,4327767631,02096032301,6731,6730003,3770003,6660004,264002,8002,70000010,20000800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000010,34200000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
6,200
0
0
6,800
0
0
0
7,200
7,500
0
0
7,533
0
0
0
5,853
10,322
9,402
8,593
9,478
7,769
0
7,750
10,635
10,635
0
9,716
10,790
12,511
13,215
12,543
35,191
33,584
31,457
31,457
28,851
28,997
37,478
33,447
37,697
33,783
34,274
39,342
41,868
40,443
47,450
48,479
47,873
47,873
44,231
38,104
42,036
42,036
43,300
47,851
49,433
42,345
38,116
43,916
38,309
35,961
44,220
40,334
39,608
105,426
108,354
86,807
86,807
101,051
128,472
131,919
125,764
103,614
116,768
124,337
149,312
164,164
172,909
0
147,112
185,311
197,868
211,152
203,413
199,606
182,432
180,964
167,543
264,807
216,690
203,264
187,520
183,204
183,486
182,851
180,635
175,658
159,276
156,435
149,371
156,437
163,711
165,132
169,021
165,895
161,270
158,198
153,930
178,905
57,784
92,951
173,387
89,515
87,233
83,590
90,388
93,879
93,87990,38883,59087,23389,515173,38792,95157,784178,905153,930158,198161,270165,895169,021165,132163,711156,437149,371156,435159,276175,658180,635182,851183,486183,204187,520203,264216,690264,807167,543180,964182,432199,606203,413211,152197,868185,311147,1120172,909164,164149,312124,337116,768103,614125,764131,919128,472101,05186,80786,807108,354105,42639,60840,33444,22035,96138,30943,91638,11642,34549,43347,85143,30042,03642,03638,10444,23147,87347,87348,47947,45040,44341,86839,34234,27433,78337,69733,44737,47828,99728,85131,45731,45733,58435,19112,54313,21512,51110,7909,716010,63510,6357,75007,7699,4788,5939,40210,3225,8530007,533007,5007,2000006,800006,200
   > Total Current Liabilities 
4,400
0
0
4,800
0
0
0
4,100
4,500
0
0
4,353
0
0
0
3,495
8,155
7,305
6,739
6,113
5,001
0
4,901
6,461
6,461
0
5,509
6,509
7,161
7,796
7,868
17,868
19,376
18,980
18,980
23,326
23,449
30,490
21,580
24,896
20,326
19,266
20,015
21,314
19,740
25,024
27,024
25,612
25,612
22,305
18,548
19,361
19,361
16,204
21,484
22,896
20,496
18,478
24,362
19,421
18,461
18,910
17,642
18,314
17,176
16,244
14,359
14,359
13,516
17,102
33,607
40,595
37,297
37,841
47,720
70,842
77,652
52,749
0
48,788
60,943
58,188
59,185
62,421
84,049
88,709
97,308
86,176
87,185
51,613
47,019
38,383
31,358
33,580
31,763
35,984
32,336
27,018
23,009
15,109
9,120
16,280
17,587
21,000
44,023
46,217
41,511
55,793
79,361
51,502
54,054
36,855
47,808
44,613
42,783
48,834
50,933
50,93348,83442,78344,61347,80836,85554,05451,50279,36155,79341,51146,21744,02321,00017,58716,2809,12015,10923,00927,01832,33635,98431,76333,58031,35838,38347,01951,61387,18586,17697,30888,70984,04962,42159,18558,18860,94348,788052,74977,65270,84247,72037,84137,29740,59533,60717,10213,51614,35914,35916,24417,17618,31417,64218,91018,46119,42124,36218,47820,49622,89621,48416,20419,36119,36118,54822,30525,61225,61227,02425,02419,74021,31420,01519,26620,32624,89621,58030,49023,44923,32618,98018,98019,37617,8687,8687,7967,1616,5095,50906,4616,4614,90105,0016,1136,7397,3058,1553,4950004,353004,5004,1000004,800004,400
       Short-term Debt 
200
0
0
400
0
0
0
400
400
0
0
397
0
0
0
538
0
0
0
643
0
0
0
781
781
0
677
922
290
289
241
257
354
231
231
552
593
369
571
828
755
795
795
420
377
336
301
991
991
931
805
680
680
754
749
895
838
764
2,192
2,376
2,557
2,374
2,225
2,123
2,180
2,056
3,428
3,428
3,328
6,875
20,447
26,331
25,617
25,331
34,391
7,822
49,641
38,152
0
434
454
283
286
268
272
291
301
111
114
108
107
106
1,086
2,103
3,227
1,290
1,208
1,126
1,040
948
968
988
1,008
1,800
28,018
28,105
28,321
39,588
21,386
22,417
23,019
1,868
1,906
866
725
1,164
706
7061,1647258661,9061,86823,01922,41721,38639,58828,32128,10528,0181,8001,0089889689481,0401,1261,2081,2903,2272,1031,086106107108114111301291272268286283454434038,15249,6417,82234,39125,33125,61726,33120,4476,8753,3283,4283,4282,0562,1802,1232,2252,3742,5572,3762,19276483889574975468068080593199199130133637742079579575582857136959355223123135425724128929092267707817810006430005380003970040040000040000200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,779
0
0
0
7,822
0
0
0
434
0
0
0
268
272
885
301
111
114
108
107
106
104
105
35
0
0
0
0
0
0
0
0
0
26,184
26,241
26,299
37,668
20,515
20,851
21,187
0
0
0
0
0
0
00000021,18720,85120,51537,66826,29926,24126,184000000000351051041061071081141113018852722680004340007,82200098,77900000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,000
0
0
3,100
0
0
0
2,500
2,800
0
0
2,598
0
0
0
1,519
0
1,544
1,481
1,540
1,487
0
1,182
1,205
1,205
0
1,064
1,322
2,184
2,388
2,357
4,397
7,020
6,961
6,961
9,660
7,811
15,486
11,069
11,497
9,023
7,400
6,941
9,702
10,252
13,071
12,933
8,306
8,306
7,303
4,912
5,299
5,299
4,272
4,899
6,366
5,169
5,262
5,156
4,941
4,705
3,982
3,432
3,920
4,675
4,758
3,596
3,596
3,425
3,268
4,115
5,099
6,358
6,167
7,007
8,024
9,037
11,403
0
5,048
17,674
7,043
8,966
7,105
7,962
12,321
8,564
7,477
15,906
11,169
11,399
3,503
4,150
4,798
3,538
6,100
6,790
4,879
2,660
2,934
2,824
5,116
6,874
7,679
6,048
7,318
2,479
7,890
10,023
11,786
13,263
11,433
18,961
9,794
7,917
7,328
9,116
9,1167,3287,9179,79418,96111,43313,26311,78610,0237,8902,4797,3186,0487,6796,8745,1162,8242,9342,6604,8796,7906,1003,5384,7984,1503,50311,39911,16915,9067,4778,56412,3217,9627,1058,9667,04317,6745,048011,4039,0378,0247,0076,1676,3585,0994,1153,2683,4253,5963,5964,7584,6753,9203,4323,9824,7054,9415,1565,2625,1696,3664,8994,2725,2995,2994,9127,3038,3068,30612,93313,07110,2529,7026,9417,4009,02311,49711,06915,4867,8119,6606,9616,9617,0204,3972,3572,3882,1841,3221,06401,2051,2051,18201,4871,5401,4811,54401,5190002,598002,8002,5000003,100002,000
       Other Current Liabilities 
2,200
0
0
1,300
0
0
0
1,200
1,300
0
0
1,358
0
0
0
1,438
7,927
5,241
4,783
2,367
2,905
0
3,173
3,403
3,403
0
2,064
2,460
2,155
2,293
3,001
3,591
3,032
3,211
3,211
10,586
14,043
13,840
8,114
12,366
10,548
10,924
11,542
10,630
8,783
11,481
13,206
13,896
13,896
12,252
11,412
11,710
11,710
9,527
11,370
11,773
10,876
9,402
14,485
9,576
8,888
8,283
7,941
7,222
6,933
6,506
5,945
5,945
6,066
6,322
9,045
9,164
5,322
6,343
6,322
47,353
8,048
3,117
0
37,862
32,226
40,756
46,727
51,625
64,460
72,187
79,490
76,703
69,281
38,612
33,793
34,587
26,007
26,679
24,998
28,594
22,041
20,659
19,309
11,227
5,328
10,176
9,705
11,521
9,957
10,794
7,446
8,315
47,952
17,299
17,772
23,554
26,941
33,953
34,141
40,924
31,995
31,99540,92434,14133,95326,94123,55417,77217,29947,9528,3157,44610,7949,95711,5219,70510,1765,32811,22719,30920,65922,04128,59424,99826,67926,00734,58733,79338,61269,28176,70379,49072,18764,46051,62546,72740,75632,22637,86203,1178,04847,3536,3226,3435,3229,1649,0456,3226,0665,9455,9456,5066,9337,2227,9418,2838,8889,57614,4859,40210,87611,77311,3709,52711,71011,71011,41212,25213,89613,89613,20611,4818,78310,63011,54210,92410,54812,3668,11413,84014,04310,5863,2113,2113,0323,5913,0012,2932,1552,4602,06403,4033,4033,17302,9052,3674,7835,2417,9271,4380001,358001,3001,2000001,300002,200
   > Long-term Liabilities 
1,800
0
0
2,000
0
0
0
3,100
3,000
0
0
3,180
0
0
0
2,358
0
0
0
3,365
0
0
0
4,174
4,174
0
4,207
4,281
5,350
5,419
4,675
17,323
14,208
12,477
12,477
5,525
5,548
6,988
11,867
12,801
13,457
15,008
19,327
20,554
20,703
22,426
21,455
22,261
22,261
21,926
19,556
22,675
22,675
27,096
26,367
26,537
21,849
19,638
19,554
18,888
17,500
25,310
22,692
21,294
88,250
92,110
72,448
72,448
87,535
111,370
98,312
85,169
66,317
78,927
76,617
78,470
86,512
120,160
0
98,324
124,368
139,680
151,967
140,992
115,557
93,723
83,656
81,367
177,622
165,077
156,245
149,137
151,846
149,906
151,088
144,651
143,322
132,258
133,426
134,262
147,317
147,431
147,545
148,021
121,872
115,053
116,687
98,137
99,544
6,282
38,897
136,532
41,707
42,620
40,807
41,554
42,946
42,94641,55440,80742,62041,707136,53238,8976,28299,54498,137116,687115,053121,872148,021147,545147,431147,317134,262133,426132,258143,322144,651151,088149,906151,846149,137156,245165,077177,62281,36783,65693,723115,557140,992151,967139,680124,36898,3240120,16086,51278,47076,61778,92766,31785,16998,312111,37087,53572,44872,44892,11088,25021,29422,69225,31017,50018,88819,55419,63821,84926,53726,36727,09622,67522,67519,55621,92622,26122,26121,45522,42620,70320,55419,32715,00813,45712,80111,8676,9885,5485,52512,47712,47714,20817,3234,6755,4195,3504,2814,20704,1744,1740003,3650002,3580003,180003,0003,1000002,000001,800
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
734
547
555
594
614
156
111,724
113,038
114,382
115,734
117,178
118,631
120,132
121,686
123,258
124,879
126,520
128,210
141,461
141,774
142,086
142,397
116,525
108,074
109,934
0
0
0
0
0
0
0
0
0
0
0000000000109,934108,074116,525142,397142,086141,774141,461128,210126,520124,879123,258121,686120,132118,631117,178115,734114,382113,038111,7241566145945555477340000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000010,34200000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
246
246
226
1,788
1,344
0
1,528
3,259
0
0
2,834
2,741
3,789
3,822
3,088
15,387
0
10,484
2,077
3,147
3,023
4,544
7,974
9,838
10,615
12,241
16,672
17,487
17,666
19,403
18,341
19,375
19,683
19,233
17,119
20,695
20,421
24,741
23,902
23,527
19,041
16,783
17,730
17,208
0
0
0
19,354
0
23,329
0
12,200
23,974
24,360
25,123
9,827
9,626
9,456
8,554
2,333
2,094
2,206
0
96,289
120,151
138,892
151,233
140,445
115,002
93,129
83,042
81,002
65,898
52,039
41,863
43,378
30,779
27,658
28,090
20,646
17,859
5,292
4,938
4,212
4,139
4,068
3,999
3,917
3,847
5,716
5,727
5,743
0
5,792
0
0
0
0
0
0
0
00000005,79205,7435,7275,7163,8473,9173,9994,0684,1394,2124,9385,29217,85920,64628,09027,65830,77943,37841,86352,03965,89881,00283,04293,129115,002140,445151,233138,892120,15196,28902,2062,0942,3338,5549,4569,6269,82725,12324,36023,97412,200023,329019,35400017,20817,73016,78319,04123,52723,90224,74120,42120,69517,11919,23319,68319,37518,34119,40317,66617,48716,67212,24110,6159,8387,9744,5443,0233,1472,07710,484015,3873,0883,8223,7892,7412,834003,2591,52801,3441,7882262462460000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,102
0
0
0
11,581
0
0
0
10,342
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000010,34200011,58100013,102000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
-1,500
0
0
23,100
0
0
0
14,300
11,400
0
0
17,785
0
0
0
9,067
2,543
13,729
11,938
10,882
9,607
0
7,848
7,509
7,509
0
11,958
12,286
11,069
10,641
20,479
92,061
94,006
92,773
92,773
116,757
116,953
105,107
94,525
86,654
82,495
79,374
71,920
73,026
68,018
58,985
55,432
57,324
57,324
56,860
50,663
49,044
49,044
49,953
50,070
44,863
38,910
32,364
33,468
36,305
34,019
31,894
32,363
29,794
31,985
25,361
30,504
30,504
21,682
-10,064
-15,405
-9,512
78,129
57,863
40,048
24,895
22,246
13,637
0
67,865
69,699
51,145
36,833
42,069
59,082
76,728
96,463
84,563
87,054
78,546
65,742
2,780
-9,582
-17,777
-26,963
-29,199
32,067
182,125
171,200
162,266
136,504
118,880
98,957
78,244
55,232
-3,332
-12,440
-21,145
-38,166
143,192
110,149
87,739
78,384
70,288
74,663
73,848
74,070
74,07073,84874,66370,28878,38487,739110,149143,192-38,166-21,145-12,440-3,33255,23278,24498,957118,880136,504162,266171,200182,12532,067-29,199-26,963-17,777-9,5822,78065,74278,54687,05484,56396,46376,72859,08242,06936,83351,14569,69967,865013,63722,24624,89540,04857,86378,129-9,512-15,405-10,06421,68230,50430,50425,36131,98529,79432,36331,89434,01936,30533,46832,36438,91044,86350,07049,95349,04449,04450,66356,86057,32457,32455,43258,98568,01873,02671,92079,37482,49586,65494,525105,107116,953116,75792,77392,77394,00692,06120,47910,64111,06912,28611,95807,5097,5097,84809,60710,88211,93813,7292,5439,06700017,7850011,40014,30000023,10000-1,500
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
1,984
0
0
0
1,984
1,988
2,366
2,366
2,366
2,366
0
2,366
2,366
2,366
0
2,366
2,366
2,366
2,384
2,779
3,081
3,085
3,088
3,088
3,135
3,290
3,398
3,427
3,436
3,447
3,452
3,452
3,480
3,480
3,488
3,488
3,493
3,493
3,493
3,500
3,516
3,516
3,519
3,519
3,540
3,540
3,553
3,553
3,589
3,589
3,589
3,589
3,641
3,673
3,673
3,714
3,714
3,714
3,722
3,722
3,746
5,888
5,933
5,998
6,188
6,196
6,229
0
6,331
6,331
6,331
6,331
414
414
414
414
414
420
421
424
427
427
427
428
429
518
635
582
583
584
584
586
586
590
590
608
628
644
893
893
898
960
961
963
965
966
9669659639619608988938936446286085905905865865845845835826355184294284274274274244214204144144144144146,3316,3316,3316,33106,2296,1966,1885,9985,9335,8883,7463,7223,7223,7143,7143,7143,6733,6733,6413,5893,5893,5893,5893,5533,5533,5403,5403,5193,5193,5163,5163,5003,4933,4933,4933,4883,4883,4803,4803,4523,4523,4473,4363,4273,3983,2903,1353,0883,0883,0853,0812,7792,3842,3662,3662,36602,3662,3662,36602,3662,3662,3662,3661,9881,9840001,98400000000000
   Retained Earnings -799,247-794,328-789,285-786,660-772,838-745,496-716,710-680,436-616,004-585,220-557,770-537,624-474,180-447,756-425,455-403,453-383,872-384,187-372,909-361,206-392,080-391,215-388,476-379,612-371,007-357,989-294,130-278,359-274,921-263,702-254,440-276,119-305,046-319,800-326,837-305,233-286,169-279,7930-326,205-308,805-320,452-293,303-283,257-262,184-235,546-240,668-234,304-201,450-192,621-192,621-195,298-189,381-189,393-187,302-189,005-185,546-180,619-183,297-179,958-175,668-171,644-165,947-162,565-159,015-159,015-157,479-155,175-151,817-151,817-142,184-133,078-119,445-110,384-104,527-94,312-84,844-75,183-68,735-56,851-47,663-47,806-57,133-57,133-55,578-59,875-61,573-59,704-58,054-56,381-56,0540-59,386-59,386000-56,512000-47,051000-40,35700-35,000-32,500000-25,70000-20,300
   Accumulated Other Comprehensive Income 
-5,300
0
0
-5,700
0
0
0
-5,500
-5,500
0
0
-3,212
0
0
0
-5,172
0
0
0
-6,149
0
0
0
-6,648
-6,648
0
-5,532
-4,877
-4,421
-3,893
-2,936
1,176
-1,329
-1,201
-1,201
13,039
5,509
-804
-834
-2,719
-549
3,576
3,404
6,451
7,314
8,383
11,372
18,395
18,395
18,686
13,556
12,150
12,150
13,137
15,042
14,469
11,654
8,192
11,641
10,873
12,978
13,584
11,379
10,057
10,936
9,384
10,253
10,253
9,769
10,112
10,539
10,815
10,047
8,790
-2,324
-7,423
-23,716
-18,810
0
-22,657
-16,922
-18,850
-17,385
-23,565
-23,391
-22,680
-23,421
-23,266
-23,255
-23,659
-23,651
-23,416
-23,203
-22,848
-22,972
-22,806
-23,627
-22,518
-21,918
-21,051
-22,306
-22,350
-22,744
-23,940
-25,042
-26,328
-27,909
-26,341
-26,026
-25,943
-25,951
-23,167
-23,756
-24,215
-23,802
-24,580
-24,312
-24,312-24,580-23,802-24,215-23,756-23,167-25,951-25,943-26,026-26,341-27,909-26,328-25,042-23,940-22,744-22,350-22,306-21,051-21,918-22,518-23,627-22,806-22,972-22,848-23,203-23,416-23,651-23,659-23,255-23,266-23,421-22,680-23,391-23,565-17,385-18,850-16,922-22,6570-18,810-23,716-7,423-2,3248,79010,04710,81510,53910,1129,76910,25310,2539,38410,93610,05711,37913,58412,97810,87311,6418,19211,65414,46915,04213,13712,15012,15013,55618,68618,39518,39511,3728,3837,3146,4513,4043,576-549-2,719-834-8045,50913,039-1,201-1,201-1,3291,176-2,936-3,893-4,421-4,877-5,5320-6,648-6,648000-6,149000-5,172000-3,21200-5,500-5,500000-5,70000-5,300
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
363,984
366,459
368,897
374,724
385,020
387,105
389,451
391,416
393,478
427,383
430,141
433,097
433,756
434,199
434,254
434,055
434,391
497,249
615,207
565,440
566,916
542,093
544,094
546,565
549,349
553,859
560,025
572,626
0
0
0
0
0
0
0
0
0
0
0000000000572,626560,025553,859549,349546,565544,094542,093566,916565,440615,207497,249434,391434,055434,254434,199433,756433,097430,141427,383393,478391,416389,451387,105385,020374,724368,897366,459363,9840000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000-49,998-49,998-49,998-49,998-49,998-49,998-49,998-49,998-49,998-42,573-22,361-17,506-14,3380000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
24,100
0
0
54,500
0
0
0
52,300
51,900
0
0
59,370
0
0
0
59,306
0
0
0
71,177
0
0
0
64,529
71,177
0
71,178
71,178
71,178
71,854
82,209
147,679
147,828
148,019
148,019
148,389
155,817
159,364
160,667
161,120
164,441
166,658
169,591
173,479
176,669
180,192
182,756
187,253
187,253
189,856
191,086
204,543
204,543
195,862
197,456
198,498
199,384
200,577
201,571
202,462
202,998
203,726
204,697
205,489
206,757
207,602
209,158
209,158
209,649
210,406
211,002
211,473
324,378
326,397
329,677
346,582
348,571
352,423
0
362,715
366,459
368,897
374,724
385,020
387,105
375,113
373,910
371,117
384,810
380,143
383,099
383,758
384,201
384,256
384,057
384,393
447,251
565,209
565,440
566,916
542,093
544,094
546,565
549,349
553,859
560,025
572,626
589,783
603,215
848,626
851,865
855,452
874,018
880,202
886,787
891,791
896,663
896,663891,791886,787880,202874,018855,452851,865848,626603,215589,783572,626560,025553,859549,349546,565544,094542,093566,916565,440565,209447,251384,393384,057384,256384,201383,758383,099380,143384,810371,117373,910375,113387,105385,020374,724368,897366,459362,7150352,423348,571346,582329,677326,397324,378211,473211,002210,406209,649209,158209,158207,602206,757205,489204,697203,726202,998202,462201,571200,577199,384198,498197,456195,862204,543204,543191,086189,856187,253187,253182,756180,192176,669173,479169,591166,658164,441161,120160,667159,364155,817148,389148,019148,019147,828147,67982,20971,85471,17871,17871,178071,17764,52900071,17700059,30600059,3700051,90052,30000054,5000024,100



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue169,117
Cost of Revenue-15,277
Gross Profit153,840153,840
 
Operating Income (+$)
Gross Profit153,840
Operating Expense-196,239
Operating Income-42,399-42,399
 
Operating Expense (+$)
Research Development15,196
Selling General Administrative181,043
Selling And Marketing Expenses0
Operating Expense196,239196,239
 
Net Interest Income (+$)
Interest Income0
Interest Expense-10,830
Other Finance Cost-0
Net Interest Income-10,830
 
Pretax Income (+$)
Operating Income-42,399
Net Interest Income-10,830
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-49,079-35,719
EBIT - interestExpense = -49,079
-49,079
-38,002
Interest Expense10,830
Earnings Before Interest and Taxes (EBIT)-38,249-38,249
Earnings Before Interest and Taxes (EBITDA)-35,568
 
After tax Income (+$)
Income Before Tax-49,079
Tax Provision--247
Net Income From Continuing Ops-48,832-48,832
Net Income-48,832
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses211,516
Total Other Income/Expenses Net-6,68010,830
 

Technical Analysis of Avadel
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avadel. The general trend of Avadel is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avadel's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Avadel Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avadel Pharmaceuticals PLC.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8.96 < 9.7899 < 10.50.

The bearish price targets are: 8.435 > 6.38.

Know someone who trades $AVDL? Share this with them.👇

Avadel Pharmaceuticals PLC Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avadel Pharmaceuticals PLC. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avadel Pharmaceuticals PLC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avadel Pharmaceuticals PLC. The current macd is -0.07483586.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Avadel price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Avadel. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Avadel price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Avadel Pharmaceuticals PLC Daily Moving Average Convergence/Divergence (MACD) ChartAvadel Pharmaceuticals PLC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avadel Pharmaceuticals PLC. The current adx is 17.52.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Avadel shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Avadel Pharmaceuticals PLC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avadel Pharmaceuticals PLC. The current sar is 9.55932082.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Avadel Pharmaceuticals PLC Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avadel Pharmaceuticals PLC. The current rsi is 43.74. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Avadel Pharmaceuticals PLC Daily Relative Strength Index (RSI) ChartAvadel Pharmaceuticals PLC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avadel Pharmaceuticals PLC. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Avadel price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Avadel Pharmaceuticals PLC Daily Stochastic Oscillator ChartAvadel Pharmaceuticals PLC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avadel Pharmaceuticals PLC. The current cci is -127.77046104.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Avadel Pharmaceuticals PLC Daily Commodity Channel Index (CCI) ChartAvadel Pharmaceuticals PLC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avadel Pharmaceuticals PLC. The current cmo is -21.72537132.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Avadel Pharmaceuticals PLC Daily Chande Momentum Oscillator (CMO) ChartAvadel Pharmaceuticals PLC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avadel Pharmaceuticals PLC. The current willr is -67.68201495.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Avadel is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Avadel Pharmaceuticals PLC Daily Williams %R ChartAvadel Pharmaceuticals PLC Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avadel Pharmaceuticals PLC.

Avadel Pharmaceuticals PLC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avadel Pharmaceuticals PLC. The current atr is 0.42860042.

Avadel Pharmaceuticals PLC Daily Average True Range (ATR) ChartAvadel Pharmaceuticals PLC Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avadel Pharmaceuticals PLC. The current obv is -58,519,005.

Avadel Pharmaceuticals PLC Daily On-Balance Volume (OBV) ChartAvadel Pharmaceuticals PLC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avadel Pharmaceuticals PLC. The current mfi is 21.06.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Avadel Pharmaceuticals PLC Daily Money Flow Index (MFI) ChartAvadel Pharmaceuticals PLC Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avadel Pharmaceuticals PLC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Avadel Pharmaceuticals PLC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avadel Pharmaceuticals PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.740
Ma 20Greater thanMa 509.405
Ma 50Greater thanMa 1009.177
Ma 100Greater thanMa 2008.611
OpenGreater thanClose8.890
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Avadel with someone you think should read this too:
  • Are you bullish or bearish on Avadel? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avadel? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avadel Pharmaceuticals PLC

I send you an email if I find something interesting about Avadel Pharmaceuticals PLC.


Comments

How you think about this?

Leave a comment

Stay informed about Avadel Pharmaceuticals PLC.

Receive notifications about Avadel Pharmaceuticals PLC in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.